Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 6 sty 2024 · "Nadir" is a term describing when white blood cells are at their lowest, putting an individual at risk for infection and other complications. It's important to take extra precautions to reduce the risk of infections and boost the immune system.

  2. chemocare.com › what-is-chemotherapy › what-is-nadirNadir - Chemocare

    When discussing chemotherapy side effects you may hear the term nadir used, usually in reference to the blood counts, particularly white blood cell count and platelet count. Nadir basically means low point, however further explanation may clarify this term in connection with chemotherapy treatment.

  3. Introduction: We analyzed time to CA19-9 nadir during first-line chemotherapy in patients with metastatic, unresectable, and borderline resectable pancreatic ductal adenocarcinoma (PDAC) to investigate the relationship between biomarker response and duration of chemotherapy.

  4. 1 lip 2018 · Nadir hemoglobin levels during chemoradiotherapy may stratify lung cancer patients. We investigated the influence of change in hemoglobin (Hgb) levels during concurrent chemoradiotherapy (C-CRT) on outcomes of non-anemic patients with stage IIIA/B non-small cell lung cancer (NSCLC).

  5. 1 wrz 2021 · Effective dose to immune cell (EDIC), an estimated radiation dose to the circulating lymphocytes, is of significance for overall survival (OS) in non-small cell lung cancer. This study aimed to validate the EDIC’s OS effect on limited-stage small cell lung cancer (LS-SCLC).

  6. WHAT IS NADIR? Nadir is a term that basically means low point. When a person with cancer reaches their “nadir” following each chemotherapy cycle, it means that the person’s blood cell counts are the lowest they will be during that treatment cycle. Each chemotherapy treatment comes with a nadir period.

  7. 1 lut 2019 · The ALC nadir is defined as the minimum cell count during the nCRT. The optimal cut-off of ALC nadir was determined based on a receiver operating characteristic (ROC) curve by evaluating the performance of ALC nadir to identify patient with response to nCRT (Fig. 1 C).

  1. Ludzie szukają również